UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Amendment No. 1)

Under the Securities Exchange Act of 1934

 

 

Qihoo 360 Technology Co. Ltd.

 

(Name of Issuer)

Ordinary Shares*

American Depositary Shares

 

(Title of Class of Securities)

74734M109**

 

(CUSIP Number)

December 31, 2012

 

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)

 

  x Rule 13d-1(c)

 

  ¨ Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

* Not for trading, but only in connection with the registration of American Depositary Shares, each 2 representing 3 Class A ordinary shares.

** This CUSIP number applies to the American Depositary Shares.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 2 of 10 Pages

 

  (1)   

Names of reporting persons/I.R.S. identification nos. of above persons (entities only)

 

Trustbridge Partners III, L.P.

  (2)  

Check the appropriate box if a member of a group

(a)   ¨         (b)   x

 

  (3)  

SEC use only

 

  (4)  

Citizenship or place of organization

 

Cayman Islands

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (5)    

Sole voting power

 

9,898,167 1

   (6)   

Shared voting power

 

0

   (7)   

Sole dispositive power

 

9,898,167 1

   (8)   

Shared dispositive power

 

0

  (9)  

Aggregate amount beneficially owned by each reporting person

 

9,898,167 1

(10)  

Check if the aggregate amount in Row (9) excludes certain shares     ¨

 

(11)  

Percent of class represented by amount in Row (9)

 

5.4% 2

(12)  

Type of reporting person (see instructions)

 

PN

 

 

1 Includes (i) 5,220,978 American Depositary Shares (“ADSs”), each 2 representing 3 Class A ordinary shares held directly by Trustbridge Partners III, L.P. (“TB III”), and (ii) 1,224,466 ADSs managed by TB Alternative Assets Ltd. (“TB Alternative”) on behalf of the Trustees of Columbia University in the City of New York, and (iii) 153,334 ADSs managed by TB Alternative on behalf of the Ludwig Institute for Cancer Research Ltd. (“LICR”). TB III is a limited partnership whose general partner is TB Partners GP3, L.P. The general partner of TB Partners GP3, L.P. is TB Partners GP Limited. TB Alternative is affiliated with TB Partners GP Limited.

2 Percentage ownership reported based on 184,157,097 ordinary shares represented by the Issuer as outstanding as of December 31, 2012, which includes 123,472,524 Class A ordinary shares and 60,684,573 Class B ordinary shares.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 3 of 10 Pages

 

  (1)   

Names of reporting persons/I.R.S. identification nos. of above persons (entities only)

 

TB Partners GP3, L.P.

  (2)  

Check the appropriate box if a member of a group (see instructions)

(a)   ¨         (b)   x

 

  (3)  

SEC use only

 

  (4)  

Citizenship or place of organization

 

Cayman Islands

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (5)    

Sole voting power

 

9,898,167 3

   (6)   

Shared voting power

 

0

   (7)   

Sole dispositive power

 

9,898,167 3

   (8)   

Shared dispositive power

 

0

  (9)  

Aggregate amount beneficially owned by each reporting person

 

9,898,167 3

(10)  

Check if the aggregate amount in Row (9) excludes certain shares     ¨

 

(11)  

Percent of class represented by amount in Row (9)

 

5.4% 4

(12)  

Type of reporting person (see instructions)

 

PN

 

 

3 Includes (i) 5,220,978 American Depositary Shares (“ADSs”), each 2 representing 3 Class A ordinary shares held directly by Trustbridge Partners III, L.P. (“TB III”), and (ii) 1,224,466 ADSs managed by TB Alternative Assets Ltd. (“TB Alternative”) on behalf of the Trustees of Columbia University in the City of New York, and (iii) 153,334 ADSs managed by TB Alternative on behalf of the Ludwig Institute for Cancer Research Ltd. (“LICR”). TB III is a limited partnership whose general partner is TB Partners GP3, L.P. The general partner of TB Partners GP3, L.P. is TB Partners GP Limited. TB Alternative is affiliated with TB Partners GP Limited.

4 Percentage ownership reported based on 184,157,097 ordinary shares represented by the Issuer as outstanding as of December 31, 2012, which includes 123,472,524 Class A ordinary shares and 60,684,573 Class B ordinary shares.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 4 of 10 Pages

 

  (1)   

Names of reporting persons/I.R.S. identification nos. of above persons (entities only)

 

TB Partners GP Limited

  (2)  

Check the appropriate box if a member of a group (see instructions)

(a)   ¨         (b)   x

 

  (3)  

SEC use only

 

  (4)  

Citizenship or place of organization

 

Cayman Islands

Number of

shares

beneficially

owned by

each

reporting

person

with:

   (5)    

Sole voting power

 

9,898,167 5

   (6)   

Shared voting power

 

0

   (7)   

Sole dispositive power

 

9,898,167 5

   (8)   

Shared dispositive power

 

0

  (9)  

Aggregate amount beneficially owned by each reporting person

 

9,898,167 5

(10)  

Check if the aggregate amount in Row (9) excludes certain shares     ¨

 

(11)  

Percent of class represented by amount in Row (9)

 

5.4% 6

(12)  

Type of reporting person (see instructions)

 

PN

 

 

5 Includes (i) 5,220,978 American Depositary Shares (“ADSs”), each 2 representing 3 Class A ordinary shares held directly by Trustbridge Partners III, L.P. (“TB III”), and (ii) 1,224,466 ADSs managed by TB Alternative Assets Ltd. (“TB Alternative”) on behalf of the Trustees of Columbia University in the City of New York, and (iii) 153,334 ADSs managed by TB Alternative on behalf of the Ludwig Institute for Cancer Research Ltd. (“LICR”). TB III is a limited partnership whose general partner is TB Partners GP3, L.P. The general partner of TB Partners GP3, L.P. is TB Partners GP Limited. TB Alternative is affiliated with TB Partners GP Limited.

6 Percentage ownership reported based on 184,157,097 ordinary shares represented by the Issuer as outstanding as of December 31, 2012, which includes 123,472,524 Class A ordinary shares and 60,684,573 Class B ordinary shares.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 5 of 10 Pages

 

Item 1(a) Name of Issuer :

Qihoo 360 Technology Co. Ltd. (the “Issuer”)

 

Item 1(b) Address of Issuer’s Principal Executive Offices :

Block 1, Area D, Huitong Times Plaza, No. 71 Jianguo Road, Chaoyang District, Beijing 100025, People’s Republic of China

 

Item 2(a) Name of Person Filing :

TB Partners GP Limited, which is the controlling person of TB Partners GP3, L.P., which is the controlling person of Trustbridge Partners III, L.P.

TB Alternative Assets Ltd., which is an affiliate of TB Partners GP Limited.

 

Item 2(b) Address of Principal Business Office or, If None, Residence; Citizenship

The address of the principal business office for each of TB Partners GP Limited, TB Partners GP3, L.P., Trustbridge Partners III, L.P., and TB Alternative Assets Ltd. is:

Units 2001-2004, 20/F, Agricultural Bank of China Tower, 50 Connaught Road Central, Central, Hong Kong

 

Item 2(c) Citizenship

Trustbridge Partners III, L.P - Cayman Islands

TB Partners GP3, L.P. - Cayman Islands

TB Partners GP Limited - Cayman Islands

TB Alternative Assets Ltd. - Cayman Islands

 

Item 2(d) Title of Class of Securities :

Ordinary shares, par value US$0.001

American Depositary Shares

 

Item 2(e) CUSIP Number :

74734M109

 

Item 3. Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c) :

Not applicable.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 6 of 10 Pages

 

Item 4. Ownership

 

Reporting Person

   Amount
beneficially
owned:
   Percent
of class:
  Sole power
to vote or
direct

the vote:
   Shared
power to
vote or  to
direct

the vote:
   Sole power to
dispose or to
direct the
disposition
of:
   Shared power
to dispose or to
direct the
disposition of:

Trustbridge Partners III, L.P.

   9,898,167
ordinary
shares
   5.4%   9,898,167
ordinary
shares
   0    9,898,167
ordinary
shares
   0

TB Partners GP3, L.P.

   9,898,167
ordinary
shares
   5.4%   9,898,167
ordinary
shares
   0    9,898,167
ordinary
shares
   0

TB Partners GP Limited

   9,898,167
ordinary
shares
   5.4%   9,898,167
ordinary
shares
   0    9,898,167
ordinary
shares
   0

TB Alterative Assets Ltd.

   9,898,167
ordinary
shares
   5.4%   9,898,167
ordinary
shares
   0    9,898,167
ordinary
shares
   0

The percentages of ownership set forth above are based on 184,157,097 ordinary shares represented by the Issuer as outstanding as of December 31, 2012, which includes 123,472,524 Class A ordinary shares and 60,684,573 Class B ordinary shares.

TB Partners GP Limited is the controlling person of TB Partners GP3, L.P., which is the controlling person of Trustbridge Partners III, L.P. TB Alternative Assets Ltd., which is an affiliate of TB Partners GP Limited.

Pursuant to Section 13(d) of the Act, each of TB Partners GP Limited, TB Partners GP3, L.P., and TB Alternative Assets Ltd. may be deemed the beneficial owner of the Class A ordinary shares of the Issuer held by Trustbridge Partners III, L.P. Pursuant to Rule 13d-4 of the Act, each of each of TB Partners GP Limited, TB Partners GP3, L.P., and TB Alternative Assets Ltd. disclaims beneficial ownership of the Class A ordinary shares held by Trustbridge Partners III, L.P. except to the extent of their pecuniary interests therein.

Pursuant to Section 13(d) of the Act, each of TB Partners GP Limited, TB Partners GP3, L.P., Trustbridge Partners III, L.P. and TB Alternative Assets Ltd. may be deemed the beneficial owner of the Class A ordinary shares of the Issuer managed by TB Alternative Assets Ltd. on behalf of the Trustees of Columbia University in the City of New York and the Ludwig Institute for Cancer Research Ltd. Pursuant to Rule 13d-4 of the Act, each of each of TB Partners GP Limited, TB Partners GP3, L.P., Trustbridge Partners III, L.P. and TB Alternative Assets Ltd. disclaims beneficial ownership of the Class A ordinary shares held by the Trustees of Columbia University in the City of New York except to the extent of their pecuniary interests therein.

 

Item 5. Ownership of Five Percent or Less of a Class

Not applicable.

 

Item 6. Ownership of More Than Five Percent on Behalf of Another Person

Not applicable.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 7 of 10 Pages

 

Item 7. Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

Not applicable.

 

Item 9. Notice of Dissolution of Group

Not applicable.

 

Item 10. Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 8 of 10 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. In addition, by signing below, the undersigned agrees that this Schedule 13G may be filed jointly on behalf of each of the Reporting Persons.

Dated: February 7, 2013

 

TRUSTBRIDGE PARTNERS III, L.P.
By:   /s/ Shujun Li
Name:   Shujun Li
Title:   Authorized Representative
TB PARTNERS GP3, L.P.
By:   /s/ Shujun Li
Name:   Shujun Li
Title:   Authorized Representative
TB PARTNERS GP LIMITED
By:   /s/ Shujun Li
Name:   Shujun Li
Title:   Authorized Representative
TB ALTERNATIVE ASSETS LTD.
By:   /s/ Shujun Li
Name:   Shujun Li
Title:   Authorized Representative


SCHEDULE 13G

 

CUSIP No.    74734M109   Page 9 of 10 Pages

LIST OF EXHIBITS

 

Exhibit No.

  

Description

A    Joint Filing Agreement
Qihoo 360 Technology Co. Ltd. (NYSE:QIHU)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Qihoo 360 Technology Co. Ltd. Charts.
Qihoo 360 Technology Co. Ltd. (NYSE:QIHU)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Qihoo 360 Technology Co. Ltd. Charts.